Zobrazeno 1 - 10
of 13
pro vyhledávání: '"F M, Boyle"'
Autor:
C. J. Andrews, D. Ellwood, P. F. Middleton, A. Gordon, M. Nicholl, C. S. E. Homer, J. Morris, G. Gardener, M. Coory, M. Davies-Tuck, F. M. Boyle, E. Callander, A. Bauman, V. J. Flenady, on behalf of the Safer Baby Bundle collaborators
Publikováno v:
BMC Pregnancy and Childbirth, Vol 20, Iss 1, Pp 1-14 (2020)
Abstract Background In 2015, the stillbirth rate after 28 weeks (late gestation) in Australia was 35% higher than countries with the lowest rates globally. Reductions in late gestation stillbirth rates have steadily improved in Australia. However, to
Externí odkaz:
https://doaj.org/article/ae13480f926f42528e4d8a1723ef360c
Autor:
V. Flenady, G. Gardener, F. M. Boyle, E. Callander, M. Coory, C. East, D. Ellwood, A. Gordon, K. M. Groom, P. F. Middleton, J. E. Norman, K. A. Warrilow, M. Weller, A. M. Wojcieszek, C. Crowther, on behalf of the IMPACT Clinical Trials Network for Mothers’ and Babies’ Health
Publikováno v:
BMC Pregnancy and Childbirth, Vol 19, Iss 1, Pp 1-11 (2019)
Abstract Background Stillbirth is a devastating pregnancy outcome that has a profound and lasting impact on women and families. Globally, there are over 2.6 million stillbirths annually and progress in reducing these deaths has been slow. Maternal pe
Externí odkaz:
https://doaj.org/article/4aac99cfb1f24fbf8667748e7760755c
Autor:
N, Zdenkowski, P, Butow, G B, Mann, S, Fewster, C, Beckmore, R, Isaacs, C, Douglas, F M, Boyle
Publikováno v:
Internal medicine journal. 46(6)
Neoadjuvant systemic therapy (NAST) has become an established treatment option for women with operable breast cancer.We aimed to better understand NAST treatment patterns, barriers and facilitators in Australia and New Zealand.We undertook a cross-se
Publikováno v:
Journal of intellectual disability research : JIDR. 56(11)
People with intellectual disability (ID) experience health inequity compared with the general population, a key contributing factor being disparities in social determinants of health. The enactment of the United Nations Convention on the Rights of Pe
Autor:
N G, Lennox, C E, Brolan, J, Dean, R S, Ware, F M, Boyle, M, Taylor Gomez, K, van Dooren, C, Bain
Publikováno v:
Journal of intellectual disability research : JIDR. 57(10)
Health assessments for people with intellectual disability have been implemented in the UK, New Zealand and Australia, and have led to improved health outcomes. The Comprehensive Health Assessment Program (CHAP) has been shown to improve the health o
Autor:
G M, Marx, N, Pavlakis, S, McCowatt, F M, Boyle, J A, Levi, D R, Bell, R, Cook, M, Biggs, N, Little, H R, Wheeler
Publikováno v:
Journal of neuro-oncology. 54(1)
Treatment options and prognosis remains poor for patients with recurrent glioblastoma multiforme. These tumors are highly vascularised and over express angiogenic factors such as vascular endothelial growth factor and may potentially be responsive to
Publikováno v:
Journal of neuro-oncology. 41(2)
A major toxic effect of the chemotherapeutic agents paclitaxel and cisplatin is peripheral neuropathy. We report the use of a rat model of cytotoxic neuropathy to evaluate the role of glutamate as a possible neuroprotectant for these two drugs. Neuro
Autor:
F. M. Boyle, S. A. Grossman
Publikováno v:
Oncologic Therapies ISBN: 9783540781080
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::ea1a8fe9ac65a8e0632338ff0797d0b7
https://doi.org/10.1007/978-3-642-97988-0_47
https://doi.org/10.1007/978-3-642-97988-0_47
Publikováno v:
The Journal of pharmacology and experimental therapeutics. 279(1)
The dose-limiting toxicity of the chemotherapeutic agent vincristine is peripheral neuropathy, for which there is no established therapy. The amino acid glutamate has been proposed as a neuroprotectant for vincristine, but a full preclinical evaluati
Publikováno v:
Pediatrics. 96(5 Pt 1)
We proposed to measure part of the natural history of grief by determining the changes in the psychological symptoms experienced by bereaved parents over the 8 months after the loss of an infant from sudden infant death syndrome (SIDS), neonatal deat